-+ 0.00%
-+ 0.00%
-+ 0.00%

Kyverna Therapeutics shareholders elect two directors at annual meeting

PUBT·06/02/2026 20:33:02
Listen to the news
Kyverna Therapeutics shareholders elect two directors at annual meeting
  • Kyverna Therapeutics held its annual shareholder meeting on May 27, 2026.
  • Shareholders backed the selection of Ian Clark, Christi Shaw as Class II directors, with terms running to the 2029 annual meeting.
  • Shareholders ratified BDO USA, P.C. as independent registered public accounting firm for the year ending Dec. 31, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kyverna Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-253604), on June 02, 2026, and is solely responsible for the information contained therein.